P916: LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY
暂无分享,去创建一个
P. Moreau | T. Facon | K. Yong | Kenshi Suzuki | S. Macé | T. Fukao | M. Risse | T. Martin | K. Bisht | Joseph Mikhael | Nicole M. Armstrong | I. Spicka